Sadhu explains that insulin resistance can disrupt the ovarian cycle and lead to infertility by affecting hormones such as estrogen and testosterone, as well as the release of eggs from the ovaries. Taking GLP-1 agonists can help reduce insulin resistance and improve fertility in patients. However, the effects of these drugs on pregnancy are still unknown, so it is important for patients to discuss their plans for pregnancy with their doctors and consider additional contraceptive methods.
In recent years, patients taking Ozempic and Mounjaro have reported unexpected side effects related to addiction, such as a decreased desire to smoke or drink. Research suggests that the brain regions responsible for food cravings may overlap with those responsible for cravings for addictive substances. This has led to speculation that GLP-1 drugs could be used as anti-addiction medications, offering hope for patients struggling with addiction.
Christian Hendershot, an addiction researcher, notes that there are limited medications available for treating addiction, and many patients face challenges accessing them. Research funding for addiction is also lower compared to other diseases. The potential of GLP-1 drugs in combating addiction has generated interest among healthcare providers working in this field, with the hope of providing more effective treatment options for patients in need.